Dutch medtech startup IPD secures €2.1M for prosthetic joint infection treatment

Implant Preservation Devices, a Dutch startup that specialises in prosthetic joint infections, announced on Thursday, July 20, that it has raised €2.1M in a seed round of funding closed on Friday, July 14, 2023.

The company says the funds will be used to develop its first-in-human medical device for a clinical trial scheduled to commence in early 2024. 

Implant Preservation Devices: Specialising in prosthetic joint infections

Implant Preservation Devices (IPD) was founded in December 2020 by NLC, the European Healthtech Venture Builder, and Leiden University Medical Center. The startup is based in the PLNT business centre in Leiden, the Netherlands.

IPD is developing a medical device using non-contact induction heating technology to treat prosthetic joint and metal implant infections. 

By using induction technology, the implant is heated while still inside the patient, eliminating bacteria on the implant and ultimately curing the infection. 

Prosthetic joint infections are severe and life-threatening complications, affecting over 250,000 patients worldwide. 

However, laboratory studies have shown promising results for the treatment of these infections using non-contact induction technology.

With a highly experienced team alongside the innovators, Prof. Dr. R. Nelissen and Asst. Prof. Dr. B. Pijls, IPD aims at a multicenter study in 2025 and market introduction in early 2026.

NLC: Healthtech venture builder

NLC, the European health tech venture builder, identifies top-notch early-stage healthcare inventions and brings them to market in MedTech, biotech, and digital health. 

To optimise patient care and enhance its positive and sustainable impact, NLC collaborates with corporates such as Philips and healthcare and academic research institutions such as Oxford University and Mayo Clinic.

NLC is a certified B Corp and supports UN Sustainable Development Goals 3, 9, and 17. 

With its growing team of over 80 professionals and over 110 portfolio ventures built across 11 European countries, NLC is expanding its impact-driven operations to the US, and the Gulf region.